Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Aug-22 6:57 PM View:  | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 286,539 | -- | -- | (100%) 286.54K to 0 | |
| 11-Aug-22 8:53 PM View: | Epizyme, Inc. (EPZM) | 09-Aug-22 | Payment of Exercise | 373,154 | $1.39 | $518,684.00 | (57%) 658.72K to 285.56K | |
| 11-Aug-22 8:53 PM View: | Epizyme, Inc. (EPZM) | 09-Aug-22 | Option Exercise | 500,000 | $1.39 | $695,000.00 | 315% 158.72K to 658.72K | |
| 13-Jun-22 4:38 PM View: | Fate Therapeutics Inc (FATE) | 09-Jun-22 | Grant | 8,650 | -- | -- | 470% 1.84K to 10.49K | |
| 08-Jun-22 4:03 PM View: | Fate Therapeutics Inc (FATE) | 07-Jun-22 | Sale | 841 | $21.89 | $18,409.50 | (31%) 2.68K to 1.84K | |
| 06-Jun-22 4:40 PM View: | Fate Therapeutics Inc (FATE) | 03-Jun-22 | Sale | 807 | $22.80 | $18,399.60 | (30%) 2.68K to 1.87K | |
| 21-Mar-22 6:05 PM View: | Epizyme, Inc. (EPZM) | 28-Feb-22 | Grant | 2,331 | $1.27 | $2,952.21 | 1% 156.38K to 158.72K | |
| 09-Feb-22 5:40 PM View: | Epizyme, Inc. (EPZM) | 07-Feb-22 | Sale (Planned) | 1,058 | $1.50 | $1,587.00 | (< 1%) 157.44K to 156.38K | |
| 04-Feb-22 4:15 PM View: | Epizyme, Inc. (EPZM) | 02-Feb-22 | Sale (Planned) | 2,639 | $1.37 | $3,615.43 | (2%) 160.08K to 157.44K | |
| 28-Jan-22 4:15 PM View: | Epizyme, Inc. (EPZM) | 26-Jan-22 | Market Sale (Planned) | 2,922 | $2.02 | $5,902.44 | (2%) 163.0K to 160.08K | (19%) |
| 07-Dec-21 7:03 PM View: | Epizyme, Inc. (EPZM) | 06-Dec-21 | Market Sale (Planned) | 1,780 | $2.93 | $5,215.40 | (1%) 164.78K to 163.0K | (7%) |
| 18-Aug-21 8:00 AM View: | Epizyme, Inc. (EPZM) | 16-Aug-21 | Grant | 59,166 | -- | -- | 57% 104.34K to 163.51K | |
| 04-Jun-21 5:26 PM View: | Fate Therapeutics Inc (FATE) | 02-Jun-21 | Grant | 2,681 | -- | -- | 100% 0 to 2.68K | |
| 05-Feb-21 4:41 PM View: | Epizyme, Inc. (EPZM) | 04-Feb-21 | Market Sale (Planned) | 969 | $11.21 | $10,862.50 | (< 1%) 105.31K to 104.34K | (2%) |
| 02-Feb-21 9:12 PM View: | Epizyme, Inc. (EPZM) | 01-Feb-21 | Grant | 29,583 | -- | -- | 39% 75.73K to 105.31K | |
| 27-Jan-21 8:38 PM View: | Epizyme, Inc. (EPZM) | 25-Jan-21 | Market Sale (Planned) | 2,872 | $11.41 | $32,769.50 | (4%) 78.6K to 75.73K | (4%) |
| 07-Dec-20 7:00 AM View: | Epizyme, Inc. (EPZM) | 03-Dec-20 | Market Sale (Planned) | 2,522 | $13.54 | $34,147.90 | (3%) 78.61K to 76.09K | 13% |
| 30-Jun-20 8:56 AM View: | Epizyme, Inc. (EPZM) | 26-Jun-20 | Market Sale (Planned) | 1,805 | $16.15 | $29,150.80 | (2%) 80.42K to 78.61K | 27% |
| 30-Jun-20 8:56 AM View: | Epizyme, Inc. (EPZM) | 25-Jun-20 | Grant | 6,000 | -- | -- | 8% 74.42K to 80.42K | |
| 26-Mar-20 9:00 PM View: | Epizyme, Inc. (EPZM) | 25-Mar-20 | Market Sale (Planned) | 1,243 | $15.28 | $18,993.00 | (2%) 73.23K to 71.99K | 23% |
| 26-Mar-20 9:00 PM View: | Epizyme, Inc. (EPZM) | 24-Mar-20 | Grant | 1,575 | -- | -- | 2% 71.66K to 73.23K | |
| 05-Feb-20 6:02 PM View: | Epizyme, Inc. (EPZM) | 03-Feb-20 | Grant | 12,856 | -- | -- | 22% 58.8K to 71.66K | |
| 27-Jan-20 9:19 PM View: | Epizyme, Inc. (EPZM) | 27-Jan-20 | Market Sale (Planned) | 2,630 | $20.44 | $53,757.20 | (4%) 61.43K to 58.8K | 42% |
| 27-Jan-20 9:19 PM View: | Epizyme, Inc. (EPZM) | 24-Jan-20 | Market Sale (Planned) | 1,843 | $24.64 | $45,411.50 | (3%) 63.28K to 61.43K | 52% |
| 27-Jan-20 9:19 PM View: | Epizyme, Inc. (EPZM) | 23-Jan-20 | Grant | 5,000 | -- | -- | 9% 58.28K to 63.28K | |
| 06-Dec-19 4:15 PM View: | Epizyme, Inc. (EPZM) | 02-Dec-19 | Grant | 22,577 | -- | -- | 63% 35.7K to 58.28K | |
| 17-Jun-19 5:18 PM View: | Epizyme, Inc. (EPZM) | 14-Jun-19 | Market Sale (Planned) | 1,195 | $11.97 | $14,304.20 | (3%) 36.89K to 35.7K | 1% |
| 14-Jun-19 6:55 PM View: | Epizyme, Inc. (EPZM) | 12-Jun-19 | Grant | 4,000 | -- | -- | 12% 32.89K to 36.89K | |
| 28-Jan-19 8:14 PM View: | Epizyme, Inc. (EPZM) | 24-Jan-19 | Grant | 32,894 | -- | -- | 100% 0 to 32.89K |